Section 481.203 - Patient Participation(a) A person may not be considered for participation as a recipient of tetrahydrocannabinols and their derivatives through a research program unless the person is recommended to a person in charge of an approved research program and the review board by a physician who is licensed by the Texas Medical Board and is attending the person.(b) A physician may not recommend a person for the research program unless the person: (1) has glaucoma or cancer;(2) is not responding to conventional treatment for glaucoma or cancer or is experiencing severe side effects from treatment; and(3) has symptoms or side effects from treatment that may be alleviated by medical use of tetrahydrocannabinols or their derivatives.Tex. Health and Safety Code § 481.203
Amended by Acts 2015, Texas Acts of the 84th Leg. - Regular Session, ch. 1,Sec. 3.1234, eff. 4/2/2015. Acts 1989, 71st Leg., ch. 678, Sec. 1, eff. 9/1/1989.